Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already cover idempotency, read-only behavior, and non-destructiveness. The description adds useful operational context beyond annotations: the data source (openFDA), the HTTP method (GET), and per-call cost. It does not discuss rate limits or errors, but these are not critical for a simple lookup.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is compact and front-loaded with the tool identity, followed by source, cost, and endpoint. There is minor redundancy in mentioning openFDA twice, but overall the text is efficient and scannable.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a simple read-only lookup with fully documented parameters, the description plus schema and annotations cover the tool's purpose, source, cost, and request shape. The absence of an output schema is partially mitigated by naming the content types in the description, though exact return fields are not specified.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The input schema has 100% coverage: q, field, and limit each have descriptions and examples, including allowed values for field. The description adds no parameter-specific meaning, so the baseline score of 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly identifies the resource as FDA structured drug labeling and names the content areas (uses, warnings, dosage), which distinguishes it from sibling tools. It stops short of an explicit action verb like 'search' or 'retrieve,' but the endpoint and example field make the lookup intent clear.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides no guidance about when to choose this tool over alternatives, nor does it state exclusions or context conditions. It only mentions the source, price, and endpoint, leaving usage inference entirely to the title and schema.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.